2,904
edits
Certificate in Psychedelic Assisted Therapy: Difference between revisions
Certificate in Psychedelic Assisted Therapy (view source)
Revision as of 23:10, 2 May 2024
, 23:10, 2 May 2024no edit summary
mNo edit summary |
mNo edit summary |
||
| (5 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
<seo title="Psychedelic Assisted Therapy Certificate" metakeywords="CPAT, psychedelic assisted therapy australia, psychedelic assisted therapy melbourne " metadescription="What is the best psychedelic-assisted therapy courses?"/> | |||
<div class="res-img">[[File:OSPAT certificate.png|alt=Certificate in Psychedelic Assisted Therapy|center|Psychedelic medicine lecture]] | <div class="res-img">[[File:OSPAT certificate.png|alt=Certificate in Psychedelic Assisted Therapy|center|Psychedelic medicine lecture]] | ||
</div>'''A Certificate in Psychedelic Assisted Therapy (CPAT), is the result of the successful completion of a Psychedelic Assisted Therapy Course (PATC). PATCs are courses developed by various organisations (see below) in order to teach [[Guided Psychedelic Therapy|guiding clinicians]] best practice techniques when guiding patients prior, during, and following a psychedelic experience.''' | </div>'''A Certificate in Psychedelic Assisted Therapy (CPAT), is the result of the successful completion of a Psychedelic Assisted Therapy Course (PATC). PATCs are courses developed by various organisations (see below) in order to teach [[Guided Psychedelic Therapy|guiding clinicians]] best practice techniques when guiding patients prior, during, and following a psychedelic experience.''' | ||
Numerous studies<ref>'''Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.''' Eduardo Ekman Schenberg. Front Pharmacol. 2018; 9: 733. Published online 2018 Jul 5. doi: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041963/ 10.3389/fphar.2018.00733]. </ref><ref>'''Ethical and legal issues in psychedelic harm reduction and integration therapy'''. Brian Pilecki, Jason B. Luoma, Geoff J. Bathje, Joseph Rhea & Vilmarie Fraguada Narloch. Harm Reduction Journal volume 18, Article number: 40 (2021)</ref> and a systematic review<ref>'''A systematic review of psychedelic-assisted psychotherapy for mental health''': An evaluation of the current wave of research and suggestions for the future. Wheeler, S. W., & Dyer, N. L. (2020). Psychology of Consciousness: Theory, Research, and Practice, 7(3), 279–315. <nowiki>https://doi.org/10.1037/cns0000237</nowiki></ref> have concluded that supportive therapeutic guidance should be considered the standard of care in the majority of uses of psychedelic medications for the treatment of psychiatric disorders. As there is currently a world wide shortage of psychedelic integration guides<ref>'''MDMA-Therapy Expert Dr. Rick Doblin''': Boston Magazine. Initially published in 2019 accessed on 9th August 2022 via <nowiki>https://www.bostonmagazine.com/health/2019/09/10/rick-doblin/</nowiki></ref> a wide array of courses have been developed to encourage more people to become guides. Psychedelic Assisted Therapy training guidelines were initially developed in the US<ref>Developing Guidelines and Competencies for the Training of Psychedelic Therapists. Phelps, J. (2017). Journal of Humanistic Psychology, 57(5), 450–487. doi:10.1177/0022167817711304</ref> however, more recently there has been the establishment of an increasing | Numerous studies<ref>'''Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.''' Eduardo Ekman Schenberg. Front Pharmacol. 2018; 9: 733. Published online 2018 Jul 5. doi: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041963/ 10.3389/fphar.2018.00733]. </ref><ref>'''Ethical and legal issues in psychedelic harm reduction and integration therapy'''. Brian Pilecki, Jason B. Luoma, Geoff J. Bathje, Joseph Rhea & Vilmarie Fraguada Narloch. Harm Reduction Journal volume 18, Article number: 40 (2021)</ref> and a systematic review<ref>'''A systematic review of psychedelic-assisted psychotherapy for mental health''': An evaluation of the current wave of research and suggestions for the future. Wheeler, S. W., & Dyer, N. L. (2020). Psychology of Consciousness: Theory, Research, and Practice, 7(3), 279–315. <nowiki>https://doi.org/10.1037/cns0000237</nowiki></ref> have concluded that supportive therapeutic guidance should be considered the standard of care in the majority of uses of [[Psychedelics|psychedelic medications]] for the treatment of psychiatric disorders. As there is currently a world wide shortage of psychedelic integration guides<ref>'''MDMA-Therapy Expert Dr. Rick Doblin''': Boston Magazine. Initially published in 2019 accessed on 9th August 2022 via <nowiki>https://www.bostonmagazine.com/health/2019/09/10/rick-doblin/</nowiki></ref>, a wide array of courses have been developed to encourage more people to become guides. Psychedelic Assisted Therapy training guidelines were initially developed in the US<ref>Developing Guidelines and Competencies for the Training of Psychedelic Therapists. Phelps, J. (2017). Journal of Humanistic Psychology, 57(5), 450–487. doi:10.1177/0022167817711304</ref> however, more recently there has been the establishment of an increasing number of courses worldwide, these include: | ||
* '''[https://cybin.com/embark/ Embark]''' - Canadian / US proprietary training created by Cybin ltd first released in June 2022<ref>'''Models of Psychedelic-Assisted Psychotherapy''': A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model. William Brennan and Alexander B. Belser. Cybin, Inc., Toronto, ON, Canada and Fordham University, New York City, NY, United States. Front. Psychol., 02 June 2022 <nowiki>https://doi.org/10.3389/fpsyg.2022.866018</nowiki></ref>. | * '''[https://cybin.com/embark/ Embark]''' - Canadian / US proprietary training created by Cybin ltd first released in June 2022<ref>'''Models of Psychedelic-Assisted Psychotherapy''': A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model. William Brennan and Alexander B. Belser. Cybin, Inc., Toronto, ON, Canada and Fordham University, New York City, NY, United States. Front. Psychol., 02 June 2022 <nowiki>https://doi.org/10.3389/fpsyg.2022.866018</nowiki></ref>. | ||
| Line 9: | Line 9: | ||
*'''[https://www.ciis.edu/research-centers/center-for-psychedelic-therapies-and-research/about-the-certificate-in-psychedelic-assisted-therapies-and-research#:~:text=CIIS%20has%20an%20outstanding%20reputation,esteemed%20team%20led%20by%20Dr. CIIS]''' - California Institute of Integral Studies, certifies for Psychedelic Therapies and Research. | *'''[https://www.ciis.edu/research-centers/center-for-psychedelic-therapies-and-research/about-the-certificate-in-psychedelic-assisted-therapies-and-research#:~:text=CIIS%20has%20an%20outstanding%20reputation,esteemed%20team%20led%20by%20Dr. CIIS]''' - California Institute of Integral Studies, certifies for Psychedelic Therapies and Research. | ||
*'''[https://www.fluencetraining.com/training/ Fluence]''' - a private psychological services company fully owned and operated by Dr. Ingmar Gorman and Dr. Elizabeth Nielson'''.''' | *'''[https://www.fluencetraining.com/training/ Fluence]''' - a private psychological services company fully owned and operated by Dr. Ingmar Gorman and Dr. Elizabeth Nielson'''.''' | ||
*'''[https://mapspublicbenefit.com/training/ MAPS]''' - MDMA Training Therapy Program | *'''[https://mapspublicbenefit.com/training/ MAPS]''' - [[MDMA]] Training Therapy Program | ||
*'''[https://www.scptr.org/psychedelic-therapy-training-program- SCPTR]''' - ''Salt City Psychedelic Therapy & Research'' is to educate and train. This 8-week live virtual program. | *'''[https://www.scptr.org/psychedelic-therapy-training-program- SCPTR]''' - ''Salt City Psychedelic Therapy & Research'' is to educate and train. This 8-week live virtual program. | ||
In late 2022, a multidisciplinary healthcare team convened consisting of psychotherapists, psychiatrists, neuropsychopharmacologists and mental health nurses to review the content of the courses listed above. It was found whilst the content was satisfactory (see summary of analysis below) that the financial incentives behind the creation of such a course biased the content of the course itself. For example, many of the courses offered above were been created on the basis that the practitioner works within a structured clinical pathway which would require the use of proprietary medicines. As a result, to remove this potential for bias the multidisciplinary group created the world's first [[Open Source Psychedelic-Assisted Therapy]] (OSPAT) which is available for anyone to use, free of charge. | |||
== CPAT Content == | == CPAT Content == | ||
| Line 28: | Line 28: | ||
== CPAT Structure == | == CPAT Structure == | ||
All PAT training models train the practitioner to concentrate on three key phases of therapy<ref>'''The Psychotherapeutic Framing of Psychedelic Drug Administration'''. Front. Psychol., Sec. Psychology for Clinical Settings. Published: 02 June 2022, accessed on 9th August 2022 via: <nowiki>https://doi.org/10.3389/fpsyg.2022.866018</nowiki></ref>. These include: | All PAT training models train the practitioner to concentrate on three key phases of [[Psychedelic Therapy|psychedelic therapy]]<ref>'''The Psychotherapeutic Framing of Psychedelic Drug Administration'''. Front. Psychol., Sec. Psychology for Clinical Settings. Published: 02 June 2022, accessed on 9th August 2022 via: <nowiki>https://doi.org/10.3389/fpsyg.2022.866018</nowiki></ref>. These include: | ||
# '''Preparation''' session(s) make up the first stage and are intended to [[Priming|prime]] individuals to get ready to benefit from the medication. | # '''Preparation''' session(s) make up the first stage and are intended to [[Priming|prime]] individuals to get ready to benefit from the medication. | ||
| Line 39: | Line 39: | ||
* '''Types of therapy''': Legality, Ethics. | * '''Types of therapy''': Legality, Ethics. | ||
* '''Medical attributes of Psychedelics''': Current Research, Addiction, Depression, PTSD & Trauma. | * '''Medical attributes of Psychedelics''': Current Research, Addiction, Depression, PTSD & Trauma. | ||
* '''Navigating the experience''': Preparation, Spaceholding, Set and Setting: Music Theory. | * '''Navigating the experience''': Preparation, Spaceholding, Set and Setting: [[Music and Psychedelic Experiences|Music]] Theory. | ||
* '''Integration''': Harm Reduction. | * '''Integration''': Harm Reduction. | ||